Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice
暂无分享,去创建一个
B. Staels | F. Bono | R. Paumelle | P. Schaeffer | A. Gilde | N. Hennuyer | F. Dol-Gleizes | V. Visentin | A. Marés | Perrine Desitter